• Epidermolysis

    • bullosa (congenital) Q81.9
      ICD-10-CM Diagnosis Code Q81.9

      Epidermolysis bullosa, unspecified

        2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
      • acquired L12.30
        ICD-10-CM Diagnosis Code L12.30

        Acquired epidermolysis bullosa, unspecified

          2016 2017 2018 2019 2020 Billable/Specific Code
        • drug-induced L12.31
          ICD-10-CM Diagnosis Code L12.31

          Epidermolysis bullosa due to drug

            2016 2017 2018 2019 2020 Billable/Specific Code
          Use Additional
          • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
        • specified cause NEC L12.35
          ICD-10-CM Diagnosis Code L12.35

          Other acquired epidermolysis bullosa

            2016 2017 2018 2019 2020 Billable/Specific Code
      • dystrophica Q81.2
        ICD-10-CM Diagnosis Code Q81.2

        Epidermolysis bullosa dystrophica

          2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
      • letalis Q81.1
        ICD-10-CM Diagnosis Code Q81.1

        Epidermolysis bullosa letalis

          2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
        Applicable To
        • Herlitz' syndrome
      • simplex Q81.0
        ICD-10-CM Diagnosis Code Q81.0

        Epidermolysis bullosa simplex

          2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
        Type 1 Excludes
      • specified NEC Q81.8
        ICD-10-CM Diagnosis Code Q81.8

        Other epidermolysis bullosa

          2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
    • necroticans combustiformis L51.2
      ICD-10-CM Diagnosis Code L51.2

      Toxic epidermal necrolysis [Lyell]

        2016 2017 2018 2019 2020 Billable/Specific Code
      • due to drug - see Table of Drugs and Chemicals, by drug